Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Monthly Communication Reports in: April 2026

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

The list below is sorted by communication date, beginning with the most recent.

GlaxoSmithKline Inc.

Sridhar Venkatesh, General Manager and President (Corporation)

Results 1-5 of 5

  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Government Procurement, Health, Budget, Economic Development
    Communication date: 2026-04-24
    Posted date: 2026-04-27
    Communication number: 5088-680272 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Manuela Tomic, Senior Policy Advisor | Minister of Industry and Minister Responsible for Canada Economic Development for Quebec Regions | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Government Procurement, Health, Budget, Economic Development
    Communication date: 2026-04-21
    Posted date: 2026-05-15
    Communication number: 5088-680527 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Justine Frame, Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Health
    Communication date: 2026-04-21
    Posted date: 2026-05-15
    Communication number: 5088-680526 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Government Procurement, Health, Budget, Economic Development
    Communication date: 2026-04-10
    Posted date: 2026-04-13
    Communication number: 5088-676971 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Sous-ministre adjoint(e) | Préparation aux crises sanitaires Canada | Innovation, Science and Economic Development Canada (ISED)
    • Fern Bannatyne, Directeur par intérim | Public Health Agency of Canada (PHAC)
    • paul place, Conseiller(ère) en politiques | Innovation, Science and Economic Development Canada (ISED)
    • Heather Deehan, Directrice | Public Health Agency of Canada (PHAC)
    • Jacqueline Kosche, Directrice, Programmes de Contre-Mesure Médicale de Routine et Renforcement de la Chaîne D’approvisionnement | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Government Procurement, Health, Budget, Economic Development
    Communication date: 2026-04-01
    Posted date: 2026-04-02
    Communication number: 5088-675996 View monthly communication report

Return to Monthly Communication Reports by Reporting Period

Date Modified: